Olin and Huntsman Merger Clears Regulatory Hurdle

The regulatory approval marks a critical step in the proposed merger of equals, which seeks to establish a dominant North American chemical player with significant reach in Europe and Asia. Executives project the combined firm will capture more than $400 million in annual cost synergies and integration benefits by 2031. Leadership from both companies emphasized that the integration of Olin’s manufacturing and feedstock capabilities with Huntsman’s downstream product expertise will enhance margins and streamline operations across the entire chemical value chain.

Shareholders will cast their votes during special meetings scheduled for August 25, 2026. Olin’s meeting is set for 8:00 a.m. Central Time, followed by Huntsman’s at 9:00 a.m. Both sessions will be conducted via live webcast. If approved and subject to customary closing conditions, the transaction is expected to finalize in the first half of 2027. Olin President and CEO Ken Lane described the SEC’s move as a vital milestone, while Huntsman Chairman and CEO Peter Huntsman noted that the collaboration between the two teams has been central to maintaining momentum toward the closing date.